WEBULL
News
CELZ
1.950
+2.63%
0.050
CREATIVE MEDICAL TECHNOLOGY HOLDINGS ACHIEVES SECOND WHO INN MILESTONE, STRENGTHENING GLOBAL REGULATORY POSITIONING ACROSS EXPANDING CELL THERAPY PIPELINE
Reuters · 8h ago
Creative Medical achieves second WHO INN milestone
TipRanks · 8h ago
Creative Medical Technology Holdings Achieves Second WHO INN Milestone for Cell Therapy Pipeline
Reuters · 8h ago
Weekly Report: what happened at CELZ last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at CELZ last week (0126-0130)?
Weekly Report · 02/02 10:10
Weekly Report: what happened at CELZ last week (0119-0123)?
Weekly Report · 01/26 10:09
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/20 12:05
Weekly Report: what happened at CELZ last week (0112-0116)?
Weekly Report · 01/19 10:15
Creative Medical's ADAPT Trial In Chronic Lower Back Pain Shows Functional And Pain Improvements
NASDAQ · 01/13 15:50
Creative Medical announces interim data from ADAPT trial of CELZ-201
TipRanks · 01/13 14:25
Creative Medical Announces Interim 180-Day Follow-Up Data From FDA-Cleared ADAPT Clinical Trial Evaluating CELZ-201, Proprietary Perinatal Tissue-Derived Cell Therapy For Chronic Lower Back Pain
Benzinga · 01/13 14:17
Creative Medical Technology Reports Positive Interim Results for CELZ-201 in Chronic Lower Back Pain Trial
Reuters · 01/13 14:15
CREATIVE MEDICAL TECHNOLOGY HOLDINGS REACHES MAJOR CLINICAL INFLECTION POINT WITH POSITIVE INTERIM DATA FROM ADAPT TRIAL AND CELZ-201 (OLASTROCEL) IN THE TREATMENT OF CHRONIC LOWER BACK PAIN
Reuters · 01/13 14:15
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
Barchart · 01/13 08:15
Weekly Report: what happened at CELZ last week (0105-0109)?
Weekly Report · 01/12 10:14
Creative Medical Technology Holdings Secures Regulatory Approval for Burn Pit Initiative
Reuters · 01/06 14:15
CREATIVE MEDICAL TECHNOLOGY HOLDINGS RECEIVES REGULATORY APPROVAL FOR BIODEFENSE BURN PIT INITIATIVE
Reuters · 01/06 14:15
Weekly Report: what happened at CELZ last week (1229-0102)?
Weekly Report · 01/05 10:09
Shareholders Approve Full Exercise of Outstanding Warrants
TipRanks · 12/31/2025 21:35
Weekly Report: what happened at CELZ last week (1222-1226)?
Weekly Report · 12/29/2025 10:08
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.